Dongkook Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dongkook Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Chongkundang Holdings Corp
sales of 335.68 billion Korean Won [US$307.48 million]
of which 97%
KolmarBNH Co Ltd
(256.01 billion Korean Won [US$234.50 million]
of which 90%
was Biotech), and
IL-Yang Pharmaceutical Company Limited
(261.61 billion Korean Won [US$239.64 million]
Dongkook Pharmaceutical Company Limited reported sales of 309.69 billion Korean Won (US$283.68 million)
December of 2016.
increase of 19.1%
versus 2015, when the company's sales were 259.93 billion Korean Won.
Sales at Dongkook Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 93%).
Sales of Lens saw an increase
that was more than double the company's growth rate: sales were up
54.2% in 2016, from
3.42 billion Korean Won to 5.28 billion Korean Won.